Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]
A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children [Phase 1]
A Phase 1 clinical trial of doxorubicin with hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative brachytherapy for unresect…
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: A Vaccine Study for High Risk Cancers [Phase 1]
A Phase 1 cancer vaccine study has been withdrawn; it targeted neuroblastoma, rhabdomyosarcoma, and osteosarcoma.
-
CLINICAL_TRIALS withdrawal · 2013-08-27Clinical Trial Update: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma [Phase 1]
This Phase 1 trial of LY2940680 in pediatric medulloblastoma and rhabdomyosarcoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: Markers of Anthracycline-Related Cardiac Muscle Injury
The clinical trial NCT01112800 evaluating markers of anthracycline-related cardiac muscle injury in pediatric sarcoma patients has been with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.